Araştırma Makalesi

Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study

Cilt: 7 Sayı: 4 30 Aralık 2022
PDF İndir
EN TR

Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study

Öz

Objective: Post-COVID syndrome is the persistence of signs and symptoms that develop during or after COVID-19 infection for longer than 12 weeks, which cannot be explained by an alternative diagnosis. This study aimed to examine the effects of eucalyptus (Eucalyptus globulus) aromatherapy oil on dyspnea, back pain, and anxiety in patients with post-COVID syndrome.

Methods: The study included patients diagnosed with post-COVID syndrome at the chest diseases outpatient clinic of Adana City Training and Research Hospital. Before and after eucalyptus oil application, as components of post-COVID syndrome, dyspnea was evaluated using the modified Medical Research Council (mMRC) scale, back pain using the Visual Analog Scale (VAS), and anxiety using the Beck Anxiety Inventory (BAI).

Results: A total of 15 individuals, of whom 11 were female (73.3%) and 4 were male (26.7%), were included in the study. The mean age of the patients was 45.7±10.7 years, and the mean body mass index was 24.7±3.4. The mean post-treatment values of mMRC, VAS, and BAI statistically significantly decreased compared to the pre-treatment evaluation.

Conclusion: Eucalyptus aromatherapy oil inhalation was found to be effective in recovery from post-COVID syndrome symptoms, such as dyspnea, back pain, and anxiety, which affect many people across the world and can cause labor and financial losses. Therefore, we recommend considering the use of this aromatherapy oil in the complementary treatment and follow-up of these patients.


Anahtar Kelimeler

Destekleyen Kurum

NON

Proje Numarası

NON

Teşekkür

NON

Kaynakça

  1. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data 2021.
  2. Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug 11;370:m3026.
  3. Sebei K, Sakouhi F, Herchi W, Khouja ML, Boukhchina S. Chemical composition and antibacterial activities of seven Eucalyptus species essential oils leaves. Biol Res. 2015 Jan 19;48(1):7.
  4. Rasool M, Malik A, Alam MZ, Afzal M, Alam R, Arsalan HM et al. Optimization of antibacterial activity of ethanolic extracts of Eucalyptus tereticornis and Nigella sativa: Response surface Methodology. Pak J Pharm Sci. 2018 Jul;31(4):1259-1266.
  5. Juergens UR. Anti-inflammatory properties of the monoterpene 1.8-cineole: current evidence for co-medication in inflammatory airway diseases. Drug Res (Stuttg). 2014 Dec;64(12):638-46. doi: 10.1055/s-0034-1372609.
  6. Panikar S, Shoba G, Arun M, Sahayarayan JJ, Usha Raja Nanthini A, Chinnathambi A et al. Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties. J Infect Public Health. 2021 May;14(5):601-610.
  7. Rebordosa C, Plana E, Aguado J, Thomas S, Garcia-Gil E, Perez-Gutthann S, et al. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf. 2019;28(2):126-33.
  8. Ju ZY, Wang K, Cui HS, Yao Y, Liu SM, Zhou J et al. Acupuncture for neuropathic pain in adults. Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD012057.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Aralık 2022

Gönderilme Tarihi

22 Aralık 2022

Kabul Tarihi

30 Aralık 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 7 Sayı: 4

Kaynak Göster

APA
Yaşa Öztürk, G., & Berik Safçi, S. (2022). Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study. Journal of Immunology and Clinical Microbiology, 7(4), 82-87. https://doi.org/10.58854/jicm.1223171
AMA
1.Yaşa Öztürk G, Berik Safçi S. Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study. J Immunol Clin Microbiol. 2022;7(4):82-87. doi:10.58854/jicm.1223171
Chicago
Yaşa Öztürk, Gülşah, ve Sinem Berik Safçi. 2022. “Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study”. Journal of Immunology and Clinical Microbiology 7 (4): 82-87. https://doi.org/10.58854/jicm.1223171.
EndNote
Yaşa Öztürk G, Berik Safçi S (01 Aralık 2022) Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study. Journal of Immunology and Clinical Microbiology 7 4 82–87.
IEEE
[1]G. Yaşa Öztürk ve S. Berik Safçi, “Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study”, J Immunol Clin Microbiol, c. 7, sy 4, ss. 82–87, Ara. 2022, doi: 10.58854/jicm.1223171.
ISNAD
Yaşa Öztürk, Gülşah - Berik Safçi, Sinem. “Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study”. Journal of Immunology and Clinical Microbiology 7/4 (01 Aralık 2022): 82-87. https://doi.org/10.58854/jicm.1223171.
JAMA
1.Yaşa Öztürk G, Berik Safçi S. Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study. J Immunol Clin Microbiol. 2022;7:82–87.
MLA
Yaşa Öztürk, Gülşah, ve Sinem Berik Safçi. “Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study”. Journal of Immunology and Clinical Microbiology, c. 7, sy 4, Aralık 2022, ss. 82-87, doi:10.58854/jicm.1223171.
Vancouver
1.Gülşah Yaşa Öztürk, Sinem Berik Safçi. Effects of Eucalyptus Essential Oil in Post-COVID Syndrome: A Pilot Study. J Immunol Clin Microbiol. 01 Aralık 2022;7(4):82-7. doi:10.58854/jicm.1223171

Cited By

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM bir QMEL® Tıp & Yayınevi ürünüdür.